VASCULAR SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Vascular Solutions, Inc. (VASC) Over the Proposed Sale of the Company to Teleflex Incorporated

NEW YORK, Dec. 9, 2016 /PRNewswire/ -- Nadeem Faruqi, founding partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Vascular Solutions, Inc. ("Vascular" or the "Company") (NasdaqGS:VASC) for potential breaches of fiduciary duties in connection with the sale of the Company to Teleflex Incorporated for approximately $1 billion.

The Company's stockholders will only receive $56.00 in cash for each share of Vascular common stock they own. However, the offer is below the 52-week high price of $57.15 per share and a price target of $58.00 per share set by Needham & Company in October

Click here for more information: www.faruqilaw.com/VASC.  There is no cost or obligation to you.

The investigation focuses on whether Vascular's Board of Directors breached their fiduciary duties to the Company's stockholders by failing to conduct a fair sales process and whether and by how much this proposed transaction undervalues the Company to the detriment of Vascular's shareholders.

Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation.  The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation.  The firm has an experienced trial team which has achieved significant victories on behalf of the firm's clients. To keep track of the latest securities litigation news, follow us on Twitter at www.twitter.com/MergerActivity or on Facebook at www.facebook.com/FaruqiLaw.

Faruqi & Faruqi, LLP is working together in this investigation with Juan E. Monteverde from Monteverde & Associates PC.

If you own common stock in Vascular and wish to obtain additional information and protect your investments free of charge, please visit us at www.faruqilaw.com/VASC or contact Nadeem Faruqi, Esq. either via e-mail at nfaruqi@faruqilaw.com or by telephone at (877) 247-4292 or (212) 983-9330.  You may also contact Juan E. Monteverde, Esq.  either via email at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:
Faruqi & Faruqi, LLP
685 Third Avenue, 26^th Floor
New York, NY 10017
Attn: Nadeem Faruqi, Esq.
nfaruqi@faruqilaw.com
Toll Free: (877) 247-4292
Phone: (212) 983-9330

Attorney Advertising. (C) 2016 Faruqi & Faruqi, LLP.  The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).  Prior results do not guarantee or predict a similar outcome with respect to any future matter.  We are happy to discuss your particular case.

Logo - http://photos.prnewswire.com/prnh/20120119/MM38856LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vascular-shareholder-notice-faruqi--faruqi-llp-announces-the-investigation-of-vascular-solutions-inc-vasc-over-the-proposed-sale-of-the-company-to-teleflex-incorporated-300376099.html

SOURCE Faruqi & Faruqi, LLP